Cipterbin

· Shanghai CP Guojian Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Cipterbin, covering 2011-02-08 to 2021-11-23. Get the full timeline:

Most recent: Clinical Trial Update: Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC [Phase 4]